Takeovers Panel Receives Application on Atlas Arteria Governance Terms

Takeovers Panel Application Highlights Governance Dispute

Diamond Infraco 1 Pty Ltd, the IFM Global Infrastructure Fund subsidiary behind the ongoing takeover bid for Atlas Arteria (ASX:ALX), has escalated the contest by applying to the Takeovers Panel. The application challenges the adequacy of Atlas Arteria’s disclosure regarding key governance rights attached to its 66.67% stake in the Chicago Skyway toll road, a critical asset in the group’s portfolio.

The dispute centers on two contractual rights held by the minority partner, Ontario Teachers’ Pension Plan Board: a right of first offer (ROFO) and a put option, both embedded in the Chicago Skyway Shareholders Agreement. Diamond Infraco contends that Atlas Arteria’s public disclosures, including the initial acquisition announcement in 2022 and the recent Bidder’s Statement, fail to fully explain how these rights operate, especially in the context of a change of control triggered by the takeover bid.

Complex Governance Terms Cloud Strategic Clarity

The ROFO requires Atlas Arteria to offer its interest in Chicago Skyway to Ontario Teachers before any third-party sale, with a 180-day window for Ontario Teachers to accept. If declined, Atlas Arteria may pursue other buyers but not below the ROFO price. The put option allows Ontario Teachers, upon a change of control at Atlas Arteria, to either keep its stake with enhanced governance rights or sell it back to Atlas Arteria at fair market value plus 7.5%. Diamond Infraco argues these provisions could materially affect the value and control dynamics of the takeover bid.

Adding fuel to the controversy, Atlas Arteria issued a ROFO notice to Ontario Teachers on 22 April 2026, just days before Diamond Infraco lodged its takeover offer on 27 April. The applicant asserts it was unaware of this notice until after Atlas Arteria’s 6 May announcement rejecting the bid and that the ROFO notice itself breaches a condition of the offer. This sequence raises questions about the transparency and timing of disclosures during the critical bid period.

Atlas Arteria’s Independent Directors have publicly recommended shareholders reject the takeover, citing strategic and governance concerns. Meanwhile, the board is reportedly exploring ways to manage the put option without resorting to equity raises, underscoring the complexity of the situation. The applicant warns that any sale of the Chicago Skyway interest to third parties during the offer period, outside the ROFO terms, would breach bid conditions and potentially frustrate the takeover process.

Regulatory Process and Market Implications

The Takeovers Panel has yet to appoint a sitting Panel or decide whether to conduct proceedings, leaving the bid’s regulatory path uncertain. The application seeks orders compelling Atlas Arteria to fully disclose all information related to the ROFO, put option, and potential Chicago Skyway sale, as well as to restrict any disposal of the asset during the offer period without prior notice.

This development follows the Panel’s recent refusal to grant interim relief to Atlas Arteria aimed at delaying Diamond Infraco’s Bidder’s Statement dispatch, which allowed the takeover bid to proceed amid ongoing disputes. The contested governance rights and disclosure issues add a new layer of complexity to the takeover tussle, which already features a modest premium offer and a board urging caution to securityholders. Investors should note the heightened regulatory scrutiny and the potential for further announcements as the Panel considers the application.

Atlas Arteria’s toll road portfolio, including Chicago Skyway, had shown mixed operational results recently, with marginal revenue growth tempered by uneven traffic trends, factors that may influence the strategic rationale behind the bid and responses from stakeholders.

As the situation unfolds, the interplay between contractual rights, disclosure obligations, and takeover conditions will be pivotal in shaping the contest’s outcome and the market’s assessment of Atlas Arteria’s value and governance.